Mode
Text Size
Log in / Sign up

Multiphasic CT-based deep learning model predicts early HCC recurrence after liver transplantation

Multiphasic CT-based deep learning model predicts early HCC recurrence after liver transplantation
Photo by Shawn Day / Unsplash
Key Takeaway
Consider the MD DL model as a potential tool for predicting early HCC recurrence, but await further validation before routine use.

This retrospective cohort study assessed a multiphasic CT-based multimodal deep learning (MD DL) model designed to predict early recurrence of hepatocellular carcinoma (HCC) following liver transplantation. The analysis included 147 patients treated at Tianjin First Central Hospital between June 2014 and September 2022. The MD DL model integrated multiphasic CT imaging with clinical and laboratory parameters.

The model's predictive performance was measured using the area under the curve (AUC). In the training set, the AUC was 0.972. In the validation set, the AUC was 0.885. In the test set, the AUC was 0.985. The study reported that the MD DL model showed significantly superior predictive performance compared with other models, with all comparisons yielding p < 0.05.

Safety and tolerability data were not reported in this study. The study phase and publication type were not specified. Key limitations include the single-center design, the retrospective nature of the data, and the absence of external validation beyond the internal test set. Consequently, the generalizability of these findings to other populations or settings remains uncertain.

While the model shows promise for risk stratification, clinicians should not assume it is ready for immediate widespread adoption without further prospective validation. The lack of reported adverse events or discontinuations limits the ability to assess the safety profile of implementing such a tool in routine practice.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedMar 2026
View Original Abstract ↓
ObjectiveThis study aimed to develop a multimodal deep learning (MD DL) model integrating multiphasic computed tomography (CT) with clinical and laboratory parameters to predict early recurrence of hepatocellular carcinoma (HCC) following liver transplantation.MethodsA retrospective analysis was conducted on 147 patients with HCC who underwent liver transplantation at Tianjin First Central Hospital between June 2014 and September 2022. Patients were categorized into recurrence (n = 40) and non-recurrence (n = 107) groups. Independent risk factors for early recurrence were identified to construct a clinical-imaging model. Deep learning models were developed using both single-phase and multiphasic CT images. High-dimensional imaging features were combined with clinicoradiological parameters to establish the MD DL model. Model performance was evaluated using receiver operating characteristic curves and the DeLong test, while interpretability was assessed through SHapley Additive explanation (SHAP) analysis.ResultsIndependent risk factors for early recurrence included platelet count, alpha-fetoprotein levels > 400 ng/mL, ascites, arterial peritumoral enhancement, and portal vein tumor thrombus. The MD DL model achieved area under the curve values of 0.972, 0.885, and 0.985 in the training, validation, and test sets, respectively. These values indicated significantly superior predictive performance compared with other models (all p < 0.05). SHAP analysis identified key predictive features contributing to model performance.ConclusionThe MD DL model integrating multiphasic CT and clinical parameters demonstrated high predictive accuracy for early recurrence of HCC after liver transplantation, with diagnostic performance exceeding that of conventional models.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.